Liu et al., Am J Physiol Heart Circ Physiol 2003
(Translocation, Genetic) :
CPA increased phosphorylation of p38 MAPK , and this effect was abolished by pertussis toxin and inhibitors of the cGMP pathway
Dickenson et al., Eur J Pharmacol 2003
:
In contrast, the selective adenosine A1 receptor agonist CPA ( N6-cyclopentyladenosine ) did not inhibit forskolin mediated [ 3H ] cyclic AMP accumulation or stimulate increases in p42/p44 MAPK phosphorylation